Trials / Completed
CompletedNCT06809738
Anatomical Scale for the Prognosis of Fournier Syndrome.
Proposal for an Anatomical Scale for the Prognosis of Fournier Syndrome.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- Male
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Type of study: Case series. Universe of study: Records of patients with Fournier syndrome treated using the 3-stage reconstructive technique assigned and treated at the Mexican Social Security Institute: Regional General Hospital No. 1 of Mérida, Yucatán, during the years 2021-2024. Population under study: Patients diagnosed with Fournier syndrome.
Detailed description
The first surgical stage consists of damage limitation and extension analysis. In the second surgical stage, it was necessary to wash and prepare the area to be remodeled with the joint creation of the testicular resting space delimited by the fascia of the adductor muscles of the proximal lower limb. Finally, in the third surgical stage, the wound is remodeled and addressed. The surgery was performed in patients with extensive involvement that could not be resolved with minor surgery. The 3-stage reconstructive technique can be summarized as follows: 1. Analysis and limitation of the tissue injury. Bilateral testicular and spermatic cord dissection. 2. Formation of cutaneous flaps and bilateral inguinal neocavity. 3. Perineal-scrotal reconstruction with fascial facing and cutaneous flaps
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | reconstructive technique | 1. Analysis and limitation of the tissue injury. Bilateral testicular and spermatic cord dissection. 2. Formation of cutaneous flaps and bilateral inguinal neocavity. 3. Perineal-scrotal reconstruction with fascial facing and cutaneous flaps |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2024-12-30
- Completion
- 2024-12-31
- First posted
- 2025-02-05
- Last updated
- 2025-02-05
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06809738. Inclusion in this directory is not an endorsement.